Article ID Journal Published Year Pages File Type
3192605 Annals of Allergy, Asthma & Immunology 2009 9 Pages PDF
Abstract
In a mouse model of allergic rhinitis, a single intranasal delivery of low-dose ISS-ODN/CTB conjugate effectively protects previously sensitized mice from allergic hypersensitivity responses. With further research, ISS-ODN/CTB conjugate may serve as a new allergen-independent intranasal vaccine for the treatment of allergic rhinitis.
Related Topics
Health Sciences Medicine and Dentistry Dermatology
Preview
Immunostimulatory sequence oligdeoxynucleotide/cholera toxin B conjugate: a novel allergen-independent intranasal vaccine for allergic rhinitis
Authors
, , , , , ,